Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community With Fluvoxamine, Bromhexine, Cyproheptadine, and Niclosamide in Decreasing Recovery Time

NCT05087381 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT05087381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05087381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in Community With Fluvoxamine, Bromhexine, Cyproheptadine, and Niclosamide in Decreasing Recovery Time
Lead sponsor
Chulalongkorn University
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2021
Completion date
June 21, 2022
Enrollment
1,200 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

treatment efficacy